Patents by Inventor Philippe Piechon

Philippe Piechon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260327236
    Abstract: The invention relates to compounds which inhibit CDK2 (Cyclin-Dependent Kinase 2 or Cell Division protein Kinase 2), and to processes for the preparation of said compounds, pharmaceutical compositions comprising said compounds, and use of said compounds in the treatment of conditions, diseases and disorders mediated by CDK2.
    Type: Application
    Filed: February 17, 2026
    Publication date: October 22, 2026
    Inventors: Xin CHEN, Lauren Evelyn CONNOR, Francesca Paola Anna FABBIANI, Sajan JOSEPH, Keith Bruce PFISTER, Philippe PIECHON, Vivek RAUNIYAR, Michael Robert TURNER
  • Patent number: 8563556
    Abstract: Crystalline forms or polymorphs of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts, as well as to methods of making the same, pharmaceutical compositions comprising the same and methods of treatment using the same.
    Type: Grant
    Filed: March 18, 2009
    Date of Patent: October 22, 2013
    Assignee: Novartis AG
    Inventors: Danielle Giron, Walter Hammerschmidt, Philippe Piechon, Johanne Polasek, Andreas Schreiner, Frank Stowasser
  • Publication number: 20110021536
    Abstract: Crystalline forms or polymorphs of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts, as well as to methods of making the same, pharmaceutical compositions comprising the same and methods of treatment using the same.
    Type: Application
    Filed: March 18, 2009
    Publication date: January 27, 2011
    Applicant: NORVARTIS AG
    Inventors: Danielle Giron, Walter Hammerschmidt, Philippe Piechon, Johanne Polasek, Andreas Schreiner, Frank Stowasser